Xoma reported $-3345000 in Operating Profit for its third fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Operating Profit Change
Abbvie ABBV:US $ 4306M 135M
Agios Pharmaceuticals AGIO:US $ -89.16M 0.07M
Ardelyx ARDX:US $ -42.24M 2.6M
Biomarin Pharmaceutical BMRN:US $ -53.22M 64.89M
Bluebird Bio BLUE:US $ -216.95M 23.88M
Celldex Therapeutics CLDX:US $ -20.82M 7.38M
Chimerix CMRX:US -18600000 785K
Curis CRIS:US $ -10.05M 0.6M
Eli Lilly And LLY:US $ 1476M 72.6M
Emergent Biosolutions EBS:US $ -34.7M 49.2M
Epizyme EPZM:US $ -64140000 5.91M
Intercept Pharmaceuticals ICPT:US $ 10.29M 9.53M
Life Technologies LIFE:US $ -7.73M 2.72M
Macrogenics MGNX:US $ -52987000 12.71M
Novartis NOVN:VX 3.23B 246M
Novartis NVS:US $ 3233M 246M
Pfizer PFE:US $ 7647M 1733M
Prothena PRTA:US 109.23M 81.28M
Regeneron Pharmaceuticals REGN:US $ 1847.2M 1500M
Teva Pharmaceutical Industries TEVA:US $ 623M 41M
Xoma XOMA:US $ -3345000 19K
YTE INCY:US $ 235.41M 94.57M